Thus, TRPV1 antagonists could further be used to relieve chronic pains experienced in neuropathy and cancer, and, as an example, PnTx3-5 treatment may overcome the use of morphine due to its absence of in vivo side effects, such as locomotor disorder or tolerance. This evidence concerns the gene TRPV1 and cancer.